PER 3.37% 8.6¢ percheron therapeutics limited

Could Antisense be the next multi-billion Duchenne Muscular Dystrophy biotech? Health, page-11

  1. 8,052 Posts.
    lightbulb Created with Sketch. 578
    I have only ever had awful experiences with options at this end of the market, they look so seductive, but then time decay kicks in and next thing you know you lose everything. At least with the head stock you stay in the game . Even now I'm looking at those oppies and they look soo tempting, but they are actually more expensive then they look due to time decay. Safer to buy the heads
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.